3 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow zircon: new trials by email Literature Review of zircon trials Research Report on zircon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia. Sodium zirconium cyclosilicate, Placebo - Hyperkalemia | Phase 3 | Completed | ZS Pharma, Inc. | 258 | 2014-03-31 | 2018-12-07 |
| Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia Zirconium silicate (acute phase), Zirconium silicate (subacute phase), Placebo (acute phase) - Hyperkalemia | Phase 3 | Completed | ZS Pharma, Inc. | 754 | 2012-11-30 | 2018-10-12 |
| Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia Zirconium silicate (ZS), Placebo - Hyperkalemia, Chronic Kidney Disease | Phase 2 | Completed | ZS Pharma, Inc. | 90 | 2011-11-30 | 2018-06-29 |
Hyperkalemia (3) · Renal Insufficiency, Chronic (1)
ZS Pharma, Inc. (3)
United States (3) · Australia (2) · South Africa (1)
Henrik Rasmussen, MD (2) · Henrik Rasmussen, MD, PhD (1)
PMID 32588430, PMID 31791288, PMID 25402495, PMID 25415807, PMID 29728199